Informations techniques
Exploitant
Laboratoire PROCTER & GAMBLE PHARMACEUTICALS FRANCE
Présentation
INTRINSA 300 µg/24 h, dispositif transdermique Boîte de 8 - Code CIP : 376 704-4
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
WrnhBCB93FaqHrfm